Benjamin Supnet, MD
Obstetrics & Gynecology · Corpus Christi, TXNPI 1508862723
Payments from drug & device makers
Across 118 payments — averaging $343.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$29K
- Organon$10K
- AbbVie$376
- Sumitomo Pharma America, Inc.$255
- Sage Therapeutics, LLC$143
- Biogen$97
- plus $413 from 14 others
What the payments were for
- Speaking & faculty fees$16,54891%
- Travel & lodging$1371%
- Food & beverage$1,5989%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 25 | $29,038 |
| Organon | 24 | $10,243 |
| AbbVie(2 entities) | 23 | $376 |
| Sumitomo Pharma America, Inc. | 18 | $255 |
| Sage Therapeutics, LLC | 7 | $143 |
| Biogen | 1 | $97 |
| Hologic Sales And Service, LLC | 2 | $83 |
| Myovant Sciences Inc. | 2 | $44 |
| Integra Lifesciences Corporation | 2 | $42 |
| Astellas Pharma US Inc | 2 | $39 |
| Exeltis, USA Inc. | 2 | $35 |
| Baxter Healthcare | 1 | $34 |
| Coopersurgical, Inc. | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Davol Inc. | 1 | $22 |
| Duchesnay USA Incorporated | 1 | $19 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Mission Pharmacal Company | 1 | $12 |
| Aspira Women's Health Inc | 1 | $9 |
| Unified Women's Healthcare, LP | 1 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$16,448
How this compares
$40,565 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 14 | $8,206 |
| Estradiol | 57 | $3,064 |
| ValacyclovirValacyclovir Hcl | 14 | $724 |
| Ibandronate Sodium | 17 | $350 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $235 |
| ProgesteroneProgesterone, Micronized | 11 | $232 |
| Medroxyprogesterone Acetate | 18 | $223 |
| Metronidazole | 15 | $86 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 13 | $79 |
| Ibuprofen | 14 | $67 |
| Fluconazole | 13 | $64 |
| Alendronate Sodium | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Corpus Christi
- Charles KirkhamCorpus Christi$353K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.